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Telemedicine Cognitive Behavioral Therapy for 
Anxiety After Stroke
Proof-of-Concept Randomized Controlled Trial
Ho-Yan Yvonne Chun , PhD; Alan J. Carson, MD; Athanasios Tsanas, PhD; Martin S. Dennis, MD; Gillian E. Mead, MD;  
Clementina Calabria, MBBS; William N. Whiteley, PhD
BACKGROUND AND PURPOSE: Disabling anxiety affects a quarter of stroke survivors but access to treatment is poor. We developed 
a telemedicine model for delivering guided self-help cognitive behavioral therapy (CBT) for anxiety after stroke (TASK-CBT). 
We aimed to evaluate the feasibility of TASK-CBT in a randomized controlled trial workflow that enabled all trial procedures 
to be carried out remotely. In addition, we explored the feasibility of wrist-worn actigraphy sensor as a way of measuring 
objective outcomes in this clinical trial.
METHODS: We recruited adult community-based stroke patients (n=27) and randomly allocated them to TASK-CBT (n=14) or 
relaxation therapy (TASK-Relax), an active comparator (n=13).
RESULTS: In our sample (mean age 65 [±10]; 56% men; 63% stroke, 37% transient ischemic attacks), remote self-enrolment, 
electronic signature, intervention delivery, and automated follow-up were feasible. All participants completed all TASK-CBT 
sessions (14/14). Lower levels of anxiety were observed in TASK-CBT when compared with TASK-Relax at both weeks 6 
and 20. Mean actigraphy sensor wearing-time was 33 days (±15).
CONCLUSIONS: Our preliminary feasibility data from the current study support a larger definitive clinical trial and the use of 
wrist-worn actigraphy sensor in anxious stroke survivors.
REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03439813.
Key Words: anxiety ◼ psychotherapy ◼ stroke ◼ telemedicine ◼ workflow
Anxiety affects around a quarter of stroke survivors and can be disabling even after minor stroke or transient ischemic attack (TIA)1–3 but psychological 
care is difficult to access.4 Randomized controlled tri-
als (RCTs) have demonstrated that cognitive behavioral 
therapy (CBT) with guided self-help is effective for the 
treatment of anxiety in nonstroke populations.5,6 There 
is no definitive evidence to guide treatment for patients 
with stroke.7,8
Extra barriers to accessing face-to-face CBT for 
patients with stroke include physical immobility, the fear 
of going out alone, the fear of going to places full of 
people,3 and possible social stigma attached to seek-
ing psychological treatments. Remotely delivered CBT 
by internet, email, telephone, mobile text messaging, or 
video calling (telemedicine) makes it possible to central-
ize resources for staff, training, quality monitoring, and 
cross coverage of large geographic areas, reducing cost 
and improving access. Meta-analyses have demonstrated 
guided internet-based CBT is superior to waitlist control 
and as efficacious as face-to-face CBT in treating anxi-
ety disorders or depression in adults without stroke.9,10 
D
ow
nloaded from
 http://ahajournals.org by on June 30, 2020
OR
IG
IN
AL
 C
ON
TR
IB
UT
IO
N
Chun et al Telemedicine CBT for Anxiety Post-Stroke
2  August 2020 Stroke. 2020;51:00–00. DOI: 10.1161/STROKEAHA.120.029042
We co-produced a telemedicine guided self-help CBT 
intervention with patients with anxiety after stroke (TASK-
CBT).11 Additionally, we planned to use a wrist-worn 
actigraphy sensor (noninvasive method of monitoring rest 
and activity cycles) to obtain longitudinal data, offering 
potentially novel insights into daily living aspects of stroke 
survivors in community studies. Anxious stroke survivors 
showed higher levels of avoidant behavior across a range 
of situations, for example, going out alone, social situa-
tions, physical exertion compared with those who were 
not anxious.3 Sleep disturbances are clinical features in 
both anxiety and depression. Actigraphy offers the poten-
tial of gathering objectively measured data with minimal 
participant effort in clinical trials.
In this study, we aimed to demonstrate that it is fea-
sible to (1) recruit and follow up remotely, (2) deliver 
CBT remotely, and (3) use an actigraphy sensor to col-
lect continuous data in community-dwelling patients with 
stroke/TIA with anxiety.
METHODS
The data that support the findings of this study are available 
from the corresponding author on reasonable request as per 
the journal’s Transparency and Openness Promotion Guidelines.
The TASK RCT protocol was published11 and registered 
(20/2/2018) at ClinicalTrials.gov (NCT03439813). Favorable 
opinion was obtained from local research ethics committee 
(South East Scotland 17/SS/0143). All participants provided 
written informed consent using a web-form.
Trial Design
The TASK feasibility trial was a parallel 2-armed RCT compar-
ing TASK-CBT with relaxation control (TASK-Relax; Figure 1).
Patient Population—Inclusion and Exclusion Criteria
We recruited community-based adult stroke or TIA (probable, 
definite, or ocular) patients who were anxious (at least one 
positive response on our 6-item anxiety screening questions)11; 
had access to the internet and telephone; were able to speak 
English; gave informed consent; and lived within the catchment 
population of National Health Service Lothian—the sole pro-
vider of stroke and TIA services for a population of 800 000 
people in the Lothian regions of Scotland, United Kingdom.
Recruitment Methods
Potential participants could view project information at www.
task4stroke.org12 and complete informed consent with an 
electronic signature securely on this website, which uses the 
HIPAA-compliant Research Electronic Data Caputre (REDCap) 
application.13 We sent postal invitations to eligible participants 
identified from the National Health Service Lothian Stroke Audit 
register and previous observational studies. No financial incen-
tives were offered. In addition, we offered trial information to 
stroke and TIA patients during their 1-month telephone follow-up.
Verifying Eligibility Remotely and Informed Consent
We verified eligibility with electronic health records. Baseline 
data were collected remotely including age, sex, stroke/TIA 
diagnosis, past history of, or medications for anxiety or mood; 
a telephone verbal fluency test (words beginning with F in one 
minute), modified Rankin Scale score,14 7-item generalized 
anxiety disorder,15 modified fear questionnaire,3,16 patient health 
questionnaire-2,17 and EuroQol-5D5L.18
Intervention and Comparator
The TASK-CBT intervention was delivered remotely via the tele-
phone, a treatment website, email, and mobile text. Participant 
allocated to TASK-CBT received 6 weekly telephone sessions 
(35–45 minutes each), delivered by the TASK therapist—a 
stroke physician (Dr Chun) trained in CBT with supervision from 
a consultant neuropsychiatrist (Dr Carson) using an electronic 
TASK therapist’s manual. Each week, the TASK-CBT partici-
pant received an online task to practise between sessions and 
was prescribed one or more of the psycho-educational videos 
on the TASK-CBT treatment website. Telephone sessions were 
audio-recorded for further validation of intervention fidelity.
Participants allocated to TASK-Relax had one introduc-
tory telephone session only. They were instructed to watch an 
introductory video and do 5 following online relaxation tasks: (1) 
audio and visually guided breathing exercise, (2) relaxing imagery 
and sounds, (3) music for relaxation, (4) audio-guided progres-
sive muscle relaxation, and (5) a selection of sounds of nature. 
Participants selected a favorite task to practise daily for 5 minutes.
Components Common to Both Groups
To promote adherence and completion of follow-up surveys, 
participants of both arms received weekly mobile text remind-
ers and a participant record card. All participants were aware 
that they would be offered access to the treatment website 
given to the other group after completion of their final follow-up 
survey at 20 weeks. Data collection was carried out at 6 and 
20 weeks post-randomization using automated electronic self-
completed surveys via emailed links.
Using a Wrist-Worn Actigraphy Sensor Throughout the 
TASK Trial
All participants were invited to wear the GENEactiv sensor,19 
which records 3-dimensional acceleration (actigraphy), light, 
and wrist-temperature. Participants could wear the sensor on 
either wrist. After the first 2 months, the duration of the sen-
sor’s rechargeable battery life, and with the participant’s agree-
ment, a second sensor was sent to the participant to wear for 
the rest of the trial. All sensors were sent and retrieved by post.
Feasibility Outcomes
We assessed participants recruited per month, completion of 
electronic consent forms, time taken for remote eligibility con-
firmation (date of randomization—date of sign up and consent 
form received) and completion of electronic follow-up. We 
assessed adherence to TASK-CBT and intervention fidelity with 
(1) % completion of each online task, (2) aggregate web usage 
Nonstandard Abbreviations and Acronyms
CBT cognitive behavioral therapy
RCT randomized controlled trial
TIA transient ischemic attack
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data from Google Analytics, and (3) review of audio-transcripts. 
We prespecified lack of feasibility as recruitment number of 
fewer than 2 participants per month; >50% of TASK-CBT 
patients dropping out after fewer than 3 telephone sessions; 
>10% noncompletion of follow-up surveys at 20 weeks, par-
ticipants reporting unwanted effects from the intervention.
Clinical Outcomes
Treatment relevant outcomes included the modified Rankin Scale 
score, 7-item generalized anxiety disorder, modified fear question-
naire, patient health questionnaire-2, EuroQol-5D5L, and a single 
question about concurrent treatment for mood or anxiety. An 
online user feedback survey automatically followed the 20-week 
online follow-up survey. We assessed the feasibility of obtaining 
useable recording for at least 14 days for each sensor worn.
Sample Size
We aimed to recruit 40 participants in this feasibility RCT. We 
did not perform a statistical sample size calculation.
Randomization and Allocation Concealment
A researcher not involved in conducting the TASK trial gener-
ated a computerized permuted block randomization sequence 
with random block sizes. The sequence was uploaded to the 
in-built randomization module within the trial’s web-based data 
management application—REDCap13 and was inaccessible to 
the TASK researcher enrolling participants. On randomization, 
baseline data were collected remotely and participants were 
given their allocated treatment website. Participants allocated 
to TASK-CBT also received an appointment for their first tele-
phone session.
Figure 1. Consort flow diagram.
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Masking
The unblinded TASK researcher delivered the allocated inter-
vention. We partially blinded participants by informing them 
they would be allocated to an anxiety treatment website. They 
were not aware of the contents of the intervention given to the 
other group.
Statistical Methods
We used descriptive statistics to summarise patient character-
istics, feasibility, and clinical outcomes. We used Google analyt-
ics20 for measuring aggregate web usage.
Mining the Actigraphy Data to Extract Characteristics
We used standard algorithms to mine the actigraphy data and 
computed activity and sleep characteristics21–23 at week 6 and 
week 20 post-randomization. We computed
1. Maximum average activity over 10 consecutive hours in 
a 24-hour day and is a measure of diurnal daily activity 
(M10),
2. Least average activity over 5 consecutive hours in a 
24-hour day (L5),
3. Relative amplitude, takes into account M10 and L5: 
RA M L M L= −( ) +( )10 5 10 5/
4. Inter-daily stability: expresses the stability of activity 
across days,
5. Intradaily variability: complementary to inter-daily stability, 
characterizing variability across days,
6. Mean diurnal activity during the 24 hours when the par-
ticipant is not sleeping,
7. Mean nocturnal activity, mean activity during bedtime,
8. Percentile sleep activity, where we compute the 5th, 25th, 
50th, 75th, and 95th activity percentile during bed time,
9. Sleep duration.
RESULTS
Baseline Characteristics
We screened 1481 patients with a diagnosis of stroke 
or TIA and randomized 27 participants into TASK-CBT 
(n=14) and TASK-Relax (n=13) at a recruitment rate of 
12 participants per month between January 27, 2018 
and April 9, 2018 (Figure 1), finishing when funding 
came to an end. We recruited roughly equal numbers of 
men and women with a mean age of 65, who had expe-
rienced a minor stroke or TIA with mild disability (median 
modified Rankin Scale score=1). About a half had a his-
tory of anxiety or depression and had modest/ severe 
anxiety at baseline (Table 1).
Feasibility of Streamlined RCT Workflow 
Procedures
About a third of participants (10/27, 37%) completed 
an electronic consent form and the remainder by post. 
Confirming eligibility remotely took 1 day (IQR 3) from 
receiving consent to randomization. Hundred percent 
(27/27) completed follow ups at baseline, 6 weeks, and 
20 weeks post-randomization.
Feasibility of the TASK-CBT Intervention
All 14 participants allocated to the TASK-CBT group 
completed all 6 telephone sessions.
In the TASK-CBT group, online TASK completion was 
good for the first 3 online tasks but decreased over time 
(Table 2). Average time spent on the treatment website 
was similar in both groups (6 minutes per session) based 
on Google Analytics. Transcription of audio-recording 
was complete in only 51/84 TASK-CBT telephone ses-
sions because of budget limits. We were not able to carry 
out independent reviews of audio-transcripts.
Clinical Outcomes
Median modified Rankin Scale score was one in both 
groups at 6 and 20 weeks post-randomization. Lower 
levels of anxiety were observed at 6 and 20 weeks in the 
TASK-CBT group compared with the TASK-Relax group 
on the 7-item generalized anxiety disorder and FQ-
agoraphobia (Figure 2). Median (IQR) score on GAD at 
20 weeks was 2 (4) in TASK-CBT compared with 7 (5) 
in TASK-Relax. FQ-agoraphobic subscale at 20 weeks 
was 1.5 (1.9) in TASK-CBT compared with 12.6 (17) 
in TASK-Relax. Similar trends were found on FQ-social 
phobia and modified FQ-specific phobia (Supplement IA 
and IB in the Data Supplement).
Participant Feedback
Participant feedback on their experience of using TASK-
CBT was positive (Supplement II in the Data Supple-
ment). Most participants allocated to TASK-CBT found 
the website easy to use. Participants reported accessing 
the treatment website at least 2 days a week. Most users 
reported finding the online videos and written informa-
tion useful. Most participants reported the TASK-CBT 
treatment was helpful in overcoming their anxiety. No 
unwanted effects were reported. One participant felt 
slightly isolated.
Feasibility Outcomes of Using Wrist-Worn 
Actigraphy Sensors
All 27 participants consented to wrist-worn actigraphy 
sensor for 2 months. 19/27 (74%) agreed to wear a 
second sensor. Useable recording was available for at 
least 14 days in 25/27 (93%) participants on the first 
sensor and 17/19 (89%) on the second sensor. Mean 
wearing time was 33 days (SD 15) on the first sensor 
and 35 days (SD 16) on the second (Supplement III in 
the Data Supplement). Reasons for declining to wear the 
sensor included wrist strap being too small, skin irritation, 
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too bulky to wear, and already wearing another activity 
tracker. Data were not recorded in one sensor.
Exploratory Actigraphy Data
We visualized the 3 data modalities (3-dimensional 
acceleration, wrist-temperature, light) for a randomly 
selected participant, presented as an actogram, a stan-
dard approach for visualizing actigraphy data in circa-
dian biology (Figure 3). Figure 4 illustrates comparisons 
between 2 treatment groups (TASK-CBT versus TASK-
Relax) across various objective actigraphy characteristics 
at 20 weeks (T2). There is some noticeable difference in 
sleep-related patterns using the mean nocturnal activity 
and median sleep activity (sleep activity 50%; Figure 4).
DISCUSSION
In this feasibility RCT of anxious stroke and TIA patients, 
we demonstrated it is feasible to conduct a clinical trial 
Table 1. Baseline Characteristics (Prerandomization) of Sample
Total
 
TASK-CBT TASK-Relax
n=27 n=14 n=13
Age (mean, SD) 65 (10) range, 39–81 64 (10) 65 (10)
Men 15 56% 10 71% 5 38%
Diagnosis
 Stroke  63%  71% 0 54%
 Ischemic 16  9  7  
 ICH 1  1  0  
 TIA 10 37% 4 29% 6 46%
 Median IQR Median IQR Median IQR
Time, wks since stroke/TIA 19 21 21 20 18 24
Past history N % N % n %
 Stroke/TIA 5 19% 1 7% 4 31%
 Myocardial infarction 2 7% 2 14% 0 0%
 Anxiety disorder/depression/other 15 56% 8 57% 7 54%
Current psychotropics
  Medication, eg, SSRI/SNRI/NaSSA/TCA/BZ (not 
necessarily for anxiety/mood)
8 30% 5 36% 3 23%
On treatment to help with anxiety or mood 5 19% 1 7% 4 31%
Verbal fluency number of words per minute 13 7 14 4 11 words 6
Disability
 mRS score 1 2 1 1 1 2
 mRS score 0–1 17 63% 10 71% 7 54%
 mRS score ≥2 10 37% 4 29% 6 46%
 Mean SD Mean SD Mean SD
EQ5D-5 L-Visual analog 63 18 67 19 58 16
 Median IQR Median IQR Median IQR
Generalized anxiety
 GAD-7 (/21) 9 5 9 3 7 6
Number of probable GAD (≥6) 23 85% 11 79% 12 92%
Phobic anxiety
FQ-Agoraphobia (/40) 19 21 11 20 22 21
Number of probable agoraphobic (≥7) 18 67% 7 50% 11 85%
FQ-Social phobia (/40) 19 19 10 18 20 14
FQ-Specific phobia (/40) 17 23 16 19 19 27
Depression
 PHQ-2 (/6) 2 2 2 3 2 1
BZ indicates benzodiazepine; EQ5D, EuroQol; FQ, fear questionnaire; GAD-7, 7-item generalized anxiety disorder questionnaire; mRS, modified 
Rankin Scale; NaSSA, noradrenergic and specific serotonergic antidepressant; PHQ-2, 2-item Patient Health Questionnaire; SNRI, serotonin-
norepinephrine reuptake inhibitor; TCA, tricyclic antidepressant; and TIA, transient ischemic attack.
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remotely for the delivery of telemedicine CBT for anxiety 
after stroke.
Generalizability
Participants were relatively young, with mild disability, 
and could use the internet. Our sample size was small, 
and there were expected imbalances between the 
groups. Participants allocated to TASK-CBT took more 
antidepressants, were less disabled, and had less previ-
ous stroke/TIA than the TASK-Relax group, which could 
have biased the effect in favor of TASK-CBT. With wider 
adoption of home broadband by older people, popula-
tions who can use this intervention might increase.24 
Telephone verbal fluency was included as an easy-to-
administer screen of language and fluid-intelligence. 
Further assessment of expressive and receptive lan-
guage and written communication should be considered 
in future studies.
Limitations of Study Design
Screening the local stroke registry manually for eligi-
ble participants was time-consuming, thus limiting the 
number of patients contacted and generalizability of 
the study findings. Automation of the screening pro-
cess and generation of study invitations could poten-
tially overcome this challenge. Prospective recruitment 
was feasible but initial contact was opportunistic and 
made at the discretion of the stroke clinician during 
first presentation at clinic. A well-publicised online plat-
form for use by stroke survivors to self-screen and self-
recruit to research studies may help widen access to 
research studies. Lack of telephone sessions in TASK-
Relax could have reduced adherence, which could be 
improved in a future trial with more telephone contact 
with these participants. Reviewing audio-recorded 
transcripts was not feasible given the time and fund-
ing constraints in this study. Google Analytics provided 
only aggregate but not individual web usage data so 
would not be a suitable tool as a measure of interven-
tion fidelity. The automated data capture of online task 
completion by each participant offered a simple and 
feasible measure of intervention fidelity. We had a small 
sample size (14 in TASK-CBT and 13 in TASK-Relax) 
in this feasibility study with insufficient statistical power 
to draw conclusions on our clinical outcomes.
Remote RCT Workflow
Our remote trial design could be applied to other remote-
delivered interventions, for example, guided or unguided 
self-management. A remote trial design offers the 
potential to centralize trial staff and processes even in a 
large RCT. Screening with the local stroke registry was 
Table 2. Completion of Online Tasks by TASK-CBT Participants (n=14)
Online Tasks Task Topic
Number of Participants 
Completed Each Online Task %
Number of Times Online Task 
Was Completed
1 Self-monitoring feelings/thoughts/actions 13 93 14
2 Identify unhelpful thinking styles 14 100 17
3 Fear of stroke recurrence/ losing control 12 86 14
4 Confronting your feared situation (exposure) 8 57 12
5 Relaxation for 5 min/d Not recorded
6 Schedule an enjoyable activity 8 57 13
CBT indicates cognitive behavioral therapy.
Figure 2. Anxiety data by treatment group at week 6 and 
week 20 post-randomization.
Open dots represent data points. Box is interquartile range (IQR). 
Upper whisker extends from third quartile to the largest value no 
further than 1.5×IQR. Lower whiskers extends from first quartile 
to the smallest value at most 1.5×IQR. Data beyond the whiskers 
are outliers.
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time-consuming, though verifying eligibility with elec-
tronic health records was feasible in one site and may 
be performed with national registers. Sending electronic 
proof of identity and eligibility to the research centre, for 
example, digital photograph, electronic clinic letter via a 
secure email, or form submission system are potential 
future options for national recruitment.
Telemedicine Guided Self-Help CBT
TASK-CBT is designed as a low-intensity guided 
self-help CBT intervention delivered by appropriately 
trained and supervised stroke nurses or rehabilitation 
therapists. A telemedicine model could overcome the 
barriers in accessing psychological therapy by treat-
ing stroke patients remotely. We used relaxation as an 
Figure 3. Summary actigraphy data extracted from a GENEactiv sensor.
A, Summary of actigraphy data of a randomly selected participant (3-dimensional acceleration, wrist-temperature, and light) to illustrate data 
presentation. The vertical green transparent colour indicates automatically estimated sleep times. Transparent brown indicates nonwear times. B, 
Actogram plot for a randomly selected participant to illustrate data presentation. Green transparent colour indicates automatically estimated sleep 
times. Transparent brown indicates nonwear times.
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active comparator, a therapy that may have benefit for 
generalized anxiety but has consistently been shown to 
be inferior to CBT-based intervention for panic, phobic, 
posttraumatic stress disorders in RCTs.25 Phobic anxiety, 
rather than generalized anxiety is the predominant sub-
type post-stroke.3 Online relaxation therapy is popular, 
free, and widely used, making it a suitable comparator 
in a pragmatic RCT. RCTs of psychological therapy typi-
cally use treatment as usual as control condition which is 
known to exaggerate treatment effect.26
Use of Wrist-Worn Sensors to Collect 
Continuous Actigraphy Data in an RCT
This study demonstrated the feasibility of using wrist-
worn sensors in a stroke and TIA cohort and longitudinal 
use of the device to objectively assess therapy effects. A 
wrist-worn sensor is a convenient way to measure actig-
raphy data from which we can infer potentially clinically 
useful characteristics regarding a person’s activity and 
sleep patterns. These data could be clinically relevant 
in assessing anxiety after stroke. Passive collection of 
objective outcome measures throughout an entire RCT 
requires minimal participant effort, which in turn could 
minimize bias by reducing attrition, reliability, and inter-
rater variability problems related to patient-reported out-
come measures or observer-rated measures.
Exploratory Data From an Actigraphy Sensor
We provided indicative plots for how data might be pre-
sented to visually assess patterns and have also extracted 
a number of known actigraphy measures to characterize 
long-term activity and sleep variability. We have also illus-
trated how the computed characteristics can be used to 
compare groups (TASK-CBT versus TASK-Relax in this 
study). We found that there is no obvious difference in 
terms of the extracted activity patterns during the daily 
activities, but there seems to be some noticeably differ-
ent patterns in terms of the sleep characteristics com-
puted using mean nocturnal activity and median sleep 
activity. We postulate the sleep patterns presented in 
Figure 4 might be reflecting anxiety effects, which would 
be in accordance with the findings on anxiety measures 
Figure 4. Activity and sleep measures between TASK-CBT and TASK-Relax at 20 wk post-randomization.
IS indicates inter-daily stability; IV, intradaily variability; L5, least average activity over 5 consecutive hours in a 24-h day; M10, maximum average 
activity over 10 consecutive hours in a 24-h day; MDA, mean diurnal activity; MNA, mean nocturnal activity; 50th percentile sleep activity; sleep 
duration; and RA, relative amplitude.
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(Figure 2). The association of sleep and mental health 
(and in particular anxiety) is well reported in the research 
literature27,28; these findings tentatively support the argu-
ment that sleep characteristics might need to be further 
explored in association with CBT effects and anxiety 
management. This exploratory analysis paves the way for 
considering the use of wrist-worn actigraphy sensors in 
similar longitudinal studies both to assess inherent sub-
ject variability, potentially seasonality effects, therapeutic 
effects, and group cohort comparisons. Future work may 
investigate the association between objectively extracted 
information from actigraphy signals and patient-reported 
outcome measures or clinical assessments. Our small 
sample size limits further analyses of the actigraphy data.
CONCLUSIONS
Telemedicine-delivered CBT is a feasible model to treat 
anxiety after stroke/TIA. A remote clinical trial workflow 
was feasible and will enable a definitive study. Wrist-worn 
actigraphy sensors could help collect objective outcomes 
in future stroke trials.
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